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Introduction
============

Paxillin is a focal adhesion--associated adaptor protein involved in adhesion organization and cell migration (for review see [@bib27]). Its structure features five copies of a 13--amino acid sequence, called the LD motif in the NH~2~-terminal half and four LIM domains in the COOH-terminal half ([@bib32]; [@bib26]). A number of adhesion or signaling molecules, such as vinculin, integrin α 4 and 9, FAK, cell adhesion kinase β, integrin-linked kinase, PTP-PEST, paxillin-kinase linker, and its homologous Git1 and Git2 proteins, bind to paxillin largely through LD motif or LIM domain interactions (for review see [@bib27]).

The NH~2~-terminal half of paxillin also contains a large number of Ser-Pro epitopes, which are potential substrates for proline-directed protein kinases ([@bib22]; [@bib28]). Indeed, it has been demonstrated that c-jun NH~2~ terminus kinase (JNK) phosphorylates paxillin at Ser178 in vitro and in vivo ([@bib8]). Several protein kinases including Erk and p38MAPK, have been proposed to phosphorylate paxillin based on observations using chemical inhibitors ([@bib33]; [@bib13]; [@bib16]), but due to the potential lack of specificity of these inhibitors, the results remain to be confirmed more directly. Paxillin is also a potential substrate for cdk5, a proline-directed protein kinase that is enriched in neuronal tissues and regulates neurite outgrowth ([@bib18], [@bib19]; [@bib37]), because paxillin contains a consensus sequence (S/T)PX(K/H/R) for cdk5.

Integrin-mediated adhesions are essential for the neurite outgrowth ([@bib10]; [@bib25]; [@bib34]). Thus, it is important to understand how signaling pathways regulate cell adhesion dynamics during the process of neurite outgrowth. Paxillin is a focal adhesion--associated adaptor protein involved in the regulation of focal adhesion dynamics ([@bib15]; [@bib27]; [@bib4]; [@bib8]). It has been demonstrated that paxillin plays a key role in neurite outgrowth ([@bib10]). Moreover, expression of the v-crk oncogene protein, the binding partner for tyrosine phosphorylated paxillin, in PC12 cells promotes neurite outgrowth by both NGF and EGF-dependent pathways ([@bib7]), but tyrosine phosphorylation of paxillin does not seem to be essential for the neurite outgrowth of PC-12 cells ([@bib10]). Phosphorylation of Ser 178 on paxillin by JNK has been shown to play a key role in cell migration ([@bib8]). It has been found that paxillin band is shifted to higher molecular weight in SDS-PAGE when PC-12 cells are stimulated with NGF ([@bib25]), suggesting that serine phosphorylation of paxillin also increases upon NGF treatment, but the signaling pathways involved and the physiological role are unknown. In this paper, we demonstrate that paxillin is phosphorylated at Ser 85 by p38MAPK and cdk5/p35 in vitro, and p38MAPK is the major kinase responsible for the phosphorylation of Ser 85 on paxillin in NGF-stimulated PC-12 cells. Furthermore, p38MAPK-mediated phosphorylation of Ser 85 on paxillin is involved in NGF-induced neurite outgrowth of PC-12 cells.

Results
=======

NGF induces paxillin phosphorylation in PC-12 cells
---------------------------------------------------

To confirm NGF-stimulated paxillin phosphorylation in PC-12 cells, the cells were metabolically labeled with \[^32^P\]orthophosphate and treated with NGF. The endogenous paxillin was immunoprecipitated with antipaxillin antibodies. The samples were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The phosphorylation of paxillin was detected by autoradiography. As shown in [Fig. 1](#fig1){ref-type="fig"} A, phosphorylation of paxillin was significantly enhanced by NGF stimulation and was partially inhibited by PD98059, an Erk pathway inhibitor. The paxillin bands from [Fig. 1](#fig1){ref-type="fig"} A were excised, digested with trypsin, and subjected to 2-dimensional (2-D) phosphopeptide mapping analysis. One major spot ([Fig. 1](#fig1){ref-type="fig"} B, arrow) was observed on the 2-D maps of paxillin from NGF-treated cells, and stimulation with NGF caused a dramatic increase in the intensity of the spot ([Fig. 1](#fig1){ref-type="fig"} B). The increase was partially inhibited by PD98059, indicating that Erk pathway may be involved in the phosphorylation of paxillin in PC-12 cells.

![**NGF-stimulated paxillin phosphorylation in PC-12 cells and PD98059 partially inhibited the phosphorylation.** Cells were cultured in tissue culture dishes, labeled, treated with 25 μM PD98059 as indicated for 10 min, and stimulated with 100 ng/ml NGF for times as indicated. Cells were then lysed and paxillin was immunoprecipitated from cell lysates with antipaxillin mAb. Paxillin phosphorylation was analyzed as described in Materials and methods. Total phosphorylation of paxillin (A) and the corresponding phosphopeptide mapping analysis (B) were shown. The origins are marked by dots. One major spot is pointed to by an arrow.](200307081f1){#fig1}

cdk5, p38MAPK, and Erk are activated upon NGF stimulation
---------------------------------------------------------

To dissect the signaling pathway involved in the NGF-stimulated phosphorylation of paxillin, PC-12 cells were challenged with NGF for different times and the activation of several candidate kinases were examined. To determine the activation of cdk5, the cells were lysed with a Triton lysis buffer and cdk5 was immunoprecipitated from cell lysates. The cdk5 activities in the immunoprecipitates were measured in an in vitro kinase assay using His-tagged paxillin as substrate. As shown in [Fig. 2](#fig2){ref-type="fig"} A, cdk5 activity slowly increased with a similar time course as the NGF-induced paxillin phosphorylation. The activation of p38MAPK and Erk was examined by Western blot using phospho-specific antibodies. The phosphorylation of p38MAPK exhibited a sustained increase from 30 min after NGF stimulation and dropped after 3 h ([Fig. 2](#fig2){ref-type="fig"} B), whereas the activation of Erk reached a peak as early as 30 min and slowly went down ([Fig. 2](#fig2){ref-type="fig"} C). In a similar experiment, the activation of JNK was not detected upon NGF stimulation (unpublished data). Thus, cdk5, p38MAPK and Erk are the potential protein kinases responsible for the NGF-stimulated paxillin phosphorylation in PC-12 cells.

![**NGF-activated cdk5, p38MAPK, and erk/MAPK in PC--12 cells.** (A) Cells were treated with NGF for different times as indicated and lysed. cdk5 was immunoprecipitated from cleared cell lysates and cdk5 activities were measured by in vitro kinase assays using 5 μg paxillin as substrates. (B and C) Cells were treated with NGF for different times as indicated and lysed in SDS sample buffer. The samples were applied to SDS-PAGE, transferred to nitrocellulose membrane, probed with (B) anti--phospho-p38MAPK or (C) anti--phospho-erk/MAPK antibodies to detect the activation of the kinases.](200307081f2){#fig2}

cdk5 and p38MAPK phosphorylates Ser 85 on paxillin in vitro
-----------------------------------------------------------

To learn which protein kinase may be responsible for the NGF-induced paxillin phosphorylation, three kinases were tested for their ability to phosphorylate paxillin in vitro. Therefore, recombinant paxillin β was phosphorylated with cdk5/p35, p38MAPK, and erk/MAPK in vitro in the presence of γ-\[^32^P\]ATP, and the phosphorylated paxillin was digested with trypsin and analyzed by 2-D phosphopeptide mapping. As shown in [Fig. 3](#fig3){ref-type="fig"} A, two major spots (a and b) were observed on the 2-D map of cdk5-phosphorylated paxillin β. Substitution of Ser 244 (the consensus site for cdk5) with alanine resulted in the disappearance of spot a (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200307081/DC1>), indicating that Ser 244 is a phosphorylation site for cdk5 in vitro. The polymorphism of spot a is probably caused by the high molecular mass of the phosphopeptide (4249.59 D). Spot b is more interesting because it migrates to the same position as the major spot of in vivo phosphorylation (see [Fig. 4](#fig4){ref-type="fig"} B). A similar spot also existed in the 2-D map of p38MAPK-phosphorylated paxillin, whereas a very weak spot was observed in the same position of the map of Erk-phosphorylated paxillin ([Fig. 3](#fig3){ref-type="fig"} A).

![**cdk5 and p38MAPK directly phosphorylated Ser 85 on paxillin in vitro.** (A) His-tagged paxillin β or pax~S85A~ were incubated, respectively, with active cdk5/p35, p38MAPK, and erk/MAPK in 50 μl of kinase buffer containing 40 μM γ-\[^32^P\]ATP (10 μCi) for 30 min. The phosphorylation of paxillin β and pax~S85A~ (not depicted) and 2-D phosphopeptide mapping were analyzed. The origins are marked by dots. Two major spots are pointed to by arrows a and b, respectively. (B) MS/MS analysis of a phosphopeptide recovered from spot b.](200307081f3){#fig3}

To identify the phosphorylation site corresponding to spot b, the phosphopeptide at the spot was recovered from the cellulose plate and subjected to mass spectrometry. The parent ion was observed at m/z 2028.1656, corresponding to paxillin peptide 76-FIHQQPQSSSPVYGSSAK-93 with one phosphoryl group. A fragment ion was also detected at m/z 1930.2837, which is equivalent to the m/z of the same peptide minus 98. The coexistence of this precursor ion and its minus 98 counterpart ion indicates that a phosphorylation site is located on peptide FIHQQPQSSSPVYGSSAK. Further MS/MS analysis of the parent ion revealed the presence of a phosphoryl group at Ser 85 because the additional mass of the phosphoryl group occurs at the b~10~ ion and the y~9~ ion and all subsequent b and y ions, but not at b~3~-b~5~, b~7~-b~9~, y~6~, and y~8~ ions that do not contain Ser 85 ([Fig. 3](#fig3){ref-type="fig"} B). The observation of the loss of 98 of the b~10~ ion (b~10~-H~3~PO~4~) additionally confirms the phosphorylation of Ser 85 by cdk5 and p38MAPK in vitro. This conclusion was confirmed by site-directed mutagenesis. As shown in [Fig. 3](#fig3){ref-type="fig"} A, the spot b is absent in the 2-D maps of paxillin phosphorylated by cdk5 and p38. Thus, Ser 85 of paxillin is one of the major residues targeted by cdk5 and p38MAPK in vitro.

Ser 85 is also phosphorylated in NGF-stimulated PC-12 cells
-----------------------------------------------------------

To learn whether Ser 85 on paxillin is also phosphorylated in NGF-stimulated PC-12 cells, the cells were transfected with EGFP-paxillin β and labeled with \[^32^P\]orthophosphoric acid. EGFP-paxillin β was immunoprecipitated with an anti-GFP antibody. The samples were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The phosphorylation of EGFP-paxillin β was detected by autoradiography. As shown in [Fig. 4](#fig4){ref-type="fig"} A, phosphorylation of paxillin β was significantly enhanced by NGF stimulation (Contl and NGF 3hr). The paxillin bands from [Fig. 4](#fig4){ref-type="fig"} A were excised, digested with trypsin, and subjected to 2-D phosphopeptide mapping analysis. The map of transfected EGFP-paxillin is somewhat different from that of endogenous paxillin from PC-12 cells ([Fig. 1](#fig1){ref-type="fig"} B), probably due to the species difference of paxillin. Three major spots were observed on the 2-D maps of EGFP-paxillin β, and treatment with NGF caused an increase in the intensity of the spots ([Fig. 4](#fig4){ref-type="fig"} B). Furthermore, the spot b ([Fig. 4](#fig4){ref-type="fig"} B, arrow) comigrated with the major spot from the 2-D map of in vitro phosphorylated paxillin β ([Fig. 4](#fig4){ref-type="fig"} B). Therefore, paxillin is phosphorylated at the same site in vitro and in PC-12 cells.

![**Paxillin was phosphorylated at the same site in vitro and in NGF-stimulated PC-12 cells, and the phosphorylation was not influenced by a cdk5 inhibitor, roscovitine.** PC-12 cells stably expressing EGFP-paxillin β or -pax~S244A~ were cultured in collagen-coated dishes, labeled, treated with 100 μM roscovitine (Ros) as indicated for 10 min, and stimulated with 100 ng/ml NGF for 3 h. Cells were then lysed and EGFP fusion proteins was immunoprecipitated from cell lysates with anti-GFP pAb. Total phosphorylation of EGFP-paxillin β or EGFP-pax~S244A~ (A) and the corresponding phosphopeptide mapping analysis (B) were analyzed as described in Materials and methods. A sample from in vitro phosphorylation and a mixed sample containing paxillin phosphopeptide from in vitro phosphorylation and NGF-stimulated PC-12 cells were also analyzed by 2-D phosphopeptide mapping. The origins are marked by dots.](200307081f4){#fig4}

NGF-induced phosphorylation of Ser 85 on paxillin is not inhibited by roscovitine and is only slightly impaired by purvalanol
-----------------------------------------------------------------------------------------------------------------------------

Next, we asked whether paxillin is a substrate for cdk5 in NGF-stimulated PC-12 cells. The EGFP-paxillin β--transfected cells were labeled with \[^32^P\]orthophosphoric acid, preincubated with 50 μM roscovitine, a cdk5 inhibitor for 10 min, and then stimulated with NGF for 3 h. The phosphorylation of EGFP-paxillin β was examined as described in the previous paragraph. As shown in [Fig. 4](#fig4){ref-type="fig"} A, the NGF-induced phosphorylation of paxillin β was not inhibited by roscovitine (NGF 3hr and Ros+NGF). Further 2-D phosphopeptide analysis confirmed that no major spot in the map is inhibited by roscovitine. Purvalanol, another cdk5 inhibitor, only slightly inhibited the phosphorylation of Ser 85 on paxillin in NGF-stimulated PC-12 cells ([Fig. 5](#fig5){ref-type="fig"} B), whereas the total phosphorylation ([Fig. 5](#fig5){ref-type="fig"} A, Purvalanol+NGF 3hr) and several other spots on the map ([Fig. 5](#fig5){ref-type="fig"} B) were inhibited. Furthermore, substitution of Ser 244, the major cdk5-targeted site in vitro, with alanine had no any significant effect on either the total phosphorylation ([Fig. 4](#fig4){ref-type="fig"} A, Contl and NGF 3hr under S244A) or the major spots on the phosphopeptide map ([Fig. 4](#fig4){ref-type="fig"} B). Therefore, cdk5 is not the kinase responsible for the phosphorylation of Ser 85 on paxillin in NGF-stimulated cells.

![**Phosphorylation of Ser 85 on paxillin was abolished by a p38MAPK inhibitor SB203580.** PC-12 cells stably expressing EGFP-paxillin β was cultured in collagen-coated dishes, labeled, treated with 50 μM purvalanol or 20 μM SB203580 as indicated for 10 min, and stimulated with 100 ng/ml NGF for 3 h. Cells were then lysed and EGFP-paxillin β was immunoprecipitated from cell lysates with anti-GFP antibody. Total phosphorylation of EGFP-paxillin β (A) and the corresponding phosphopeptide mapping analysis (B) were analyzed as described in Materials and methods. The origins are marked by dots. The phosphorylation of Ser 85 is pointed to by arrows.](200307081f5){#fig5}

Phosphorylation of Ser 85 is abolished by SB203580, a p38MAPK inhibitor
-----------------------------------------------------------------------

Next, we examined whether SB203580, a p38MAPK inhibitor, influenced the phosphorylation of Ser 85 on paxillin. As shown in [Fig. 5](#fig5){ref-type="fig"} A, the phosphorylation of EGFP-paxillin β was significantly inhibited by SB203580 ([Fig. 5](#fig5){ref-type="fig"} A), and 2-D phosphopeptide mapping analysis showed that the phosphorylation of Ser 85 was completely abolished and several other spots on the map were inhibited by SB203580 ([Fig. 5](#fig5){ref-type="fig"} B). This result suggests that the phosphorylation of Ser 85 on paxillin is largely mediated by p38MAPK in NGF-stimulated PC-12 cells.

Endogenous paxillin is phosphorylated at Ser 83 in NGF-stimulated PC-12 cells
-----------------------------------------------------------------------------

To identify the major p38 phosphorylation sites on rat paxillin, the protein was isolated from a rat bladder tumor cell line (NBT-II), and phosphorylated with p38MAPK in vitro. The phosphorylated paxillin was subjected to 2-D mapping analysis. As shown in [Fig. 6](#fig6){ref-type="fig"} A, there was one major phosphorylation spot on the map. To identify the phosphorylation site, phosphopeptides were recovered from that spot and analyzed by mass spectrometry. The parent ion was detected at m/z 2054.9556, which is identical to the calculated m/z of peptide 76-YAHQQPPSPSPIYSSSTK-93 with one phosphoryl group. This peptide is homologous to human paxillin peptide 76-FIHQQPQSSSPVYGSSAKA-93 ([Fig. 6](#fig6){ref-type="fig"} C). A fragment ion was also detected at m/z 1956.9556, which is equivalent to the m/z of the same peptide minus 98, indicating that peptide YAHQQPPSPSPIYSSSTK contains a phosphorylation site. The observation of the loss of 98 of the b~8~ ion (b~8~-H~3~PO~4~) indicates that a phosphorylation site is located on fragment 76-YAHQQPPS-83, whereas the additional mass of the phosphoryl group was not detected at the b~3~-b~7~ ions ([Fig. 6](#fig6){ref-type="fig"} B). Thus, Ser 83 on rat paxillin is phosphorylated by p38MAPK in vitro.

![**Phosphorylation of endogenous paxillin at Ser 83 in NGF-stimulated PC-12 cells.** (A) Endogenous paxillin in PC-12 cells is phosphorylated at the same site where p38MAPK targeted paxillin in vitro. Rat bladder tumor cells (NBT-II) was lysed in a buffer containing 50 mM Tris-HCl, pH 7.4, 140 mM NaCl, 1% Triton X-100, 1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, and 10 μg/ml pepstatin. Rat paxillin was pulled down by GST-FAT immobilized to glutathione beads ([@bib31]). Bound proteins were eluted from beads with glutathione and phosphorylated with p38MAPK. Paxillin was subjected to 2-D phosphopeptide mapping analysis (middle). The phosphorylation of endogenous paxillin from NGF-stimulated PC-12 cells was also analyzed (left). A mixed sample containing paxillin phosphopeptide from in vitro phosphorylation and NGF-stimulated PC-12 cells were also analyzed by 2-D phosphopeptide mapping (right). The spots that comigrated are pointed by arrowheads. The origins are marked by dots. (B) Rat paxillin is phosphorylated at Ser 83 by p38MAPK. MS/MS analysis of a phosphopeptide recovered from the major spot (arrow) in middle panel of A. (C) The major phosphopeptide from rat paxillin is homologous to the phosphopeptide from human paxillin.](200307081f6){#fig6}

To learn whether endogenous paxillin is also phosphorylated at Ser 83 in NGF-induced PC-12 cells, endogenous paxillin was immunoprecipitated from \[^32^P\]orthophosphoric acid--labeled, NGF-stimulated PC-12 cells and separated by SDS-PAGE. The paxillin band was isolated, digested, and subjected to 2-D peptide mapping analysis. The endogenous paxillin sample from PC-12 cells was also mixed with the in vitro paxillin sample and subjected to 2-D peptide mapping analysis. As shown in [Fig. 6](#fig6){ref-type="fig"} A, a spot on the map of paxillin from PC-12 cells comigrated with a phosphopeptide from paxillin phosphorylated in vitro, indicating that endogenous paxillin was also phosphorylated at Ser 83 in NGF-stimulated PC-12 cells.

p38MAPK-mediated phosphorylation of paxillin is involved in NGF-induced neurite extension
-----------------------------------------------------------------------------------------

To explore the role of p38MAPK in neurite extension, the effect of SB203580 on NGF-induced neurite extension in PC-12 cells was examined. About 46% of control cells had neurites longer than two cell bodies and 28% of the cells had neurites longer than three cell bodies. Treatment with SB203580 inhibited neurite outgrowth. In the presence of 10 μM SB203580 only 19% of cells extended neurites longer than two cell bodies and 7% extended neurites longer than three cell body lengths. Treatment with 20 μM of SB203580 almost abolished the NGF-induced neurite extension of PC-12 cells (Fig. S2, A and B, available at <http://www.jcb.org/cgi/content/full/jcb.200307081/DC1>).

To assess the role of p38MAPK-mediated paxillin phosphorylation in neurite extension, PC-12 cells were transfected with EGFP-paxillin β or -pax~S85A~, and the NGF-induced neurite extension of these cells was examined. As shown in [Fig. 7](#fig7){ref-type="fig"}, whereas cells expressing EGFP-pax~S85A~ exhibited ∼20% of cells bearing neurites longer than two cell bodies and 7% of cells producing neurites longer than three cell bodies, \>50% of cells expressing wild-type (wt) EGFP-paxillin β had neurites longer than two cell bodies and ∼32% of cells had neurites longer than three cell bodies. Expression of wt EGFP-paxillin had no effect on neurite extension of PC-12 cells, which is consistent with a recent report by [@bib10]. Therefore, phosphorylation of paxillin is involved in NGF-induced neurite extension.

![**Expression of pax** ~S~ **~85A~ inhibited NGF-induced neurite extension in PC-12 cells.** Cells stably expressing EGFP-paxillin β or -pax~S85A~ were plated on collagen-coated petri dishes and treated with 100 ng/ml NGF as described in Materials and methods. The neurite outgrowth was recorded after 96 h of NGF stimulation. (A) Typical inhibition of NGF-induced neurite extension by expression of pax~S85A~. Bar, 40 μm. (B) Quantitative analysis of neurite outgrowth from \>300 cells. The data was plotted as the mean ± SD from three experiments.](200307081f7){#fig7}

p38MAPK-mediated phosphorylation of paxillin is involved in the regulation of focal adhesions
---------------------------------------------------------------------------------------------

To understand the role of phosphorylation of paxillin at Ser 85 in focal adhesion organization, the focal adhesions in PC-12 cells expressing EGFP-paxillin β or EGFP-pax~S85A~ were examined with TIRF and epifluorescence microscopy. EGFP-paxillin β localized to focal adhesions at the tips of cell processes (arrows), whereas EGFP-pax~S85A~ was more clustered in focal adhesions at the tips (arrows) and there appeared to be an increase in the number of focal adhesions ([Fig. 8, A and B](#fig8){ref-type="fig"}; [Fig. 9](#fig9){ref-type="fig"}). Staining these cells with Alexa 568--labeled antivinculin antibodies gave a similar result and showed that vinculin colocalized with paxillin at the tips of cell processes ([Fig. 9](#fig9){ref-type="fig"}). These results also demonstrate that changes in EGFP-paxillin fluorescence reflect changes in focal adhesion structure rather than simply changes in paxillin localization. Expression of a p38MAPK dominant negative mutant (p38αAF) also induced the formation of more clustered focal adhesions, whereas expression of MKK3bE, a constitutively active MAPK kinase for p38MAPK, induces focal adhesion disassembly in PC-12 cells (Fig. S3, arrows, available at <http://www.jcb.org/cgi/content/full/jcb.200307081/DC1>). Thus, phosphorylation of paxillin by p38MAPK plays an important role in focal adhesion organization in NGF-stimulated PC-12 cells.

![**Expression of pax** ~S85A~ **enhanced focal adhesion formation in NGF-treated PC-12 cells.** Cells stably expressing EGFP-paxillin β or EGFP-pax~S85A~ were plated on collagen-coated MatTek dishes and treated with 100 ng/ml NGF for 36 h. TIRF and epifluorescence images were taken as described in Materials and methods. (A) Expression of pax~S85A~ induced clustered focal adhesions. Arrows point to focal adhesions. Bar, 20 μm. (B) Quantitative analysis of focal adhesions in PC-12 cells expressing EGFP-paxillin β or EGFP-pax~S85A.~ The data was analyzed using Metamorph software and focal contacts that were longer than five pixels (1 μm) were scored.](200307081f8){#fig8}

![**Vinculin was colocalized with paxillin at the tips of neurites.** Cells stably expressing EGFP-paxillin β or EGFP-pax~S85A~ were plated on collagen-coated MatTek dishes and treated with 100 ng/ml NGF for 48 h. The cells were fixed and stained with Alexa 568--labeled antivinculin antibodies. TIRF images of EGFP-paxillin β or EGFP-pax~S85A~ (top) and vinculin (bottom) were taken as described in Materials and methods. Bar, 20 μm.](200307081f9){#fig9}

p38MAPK-mediated phosphorylation of paxillin influences the binding of Pyk2 to paxillin
---------------------------------------------------------------------------------------

To explore the possible mechanism by which paxillin phosphorylation regulates neurite extension and cell adhesions, tyrosine phosphorylation of EGFP-paxillin β, EGFP-pax~S85A~, FAK, and Src, in NGF-treated PC-12 cells expressing EGFP-paxillin β or EGFP-pax~S85A~ were examined using antiphosphotyrosine or phospho-specific antibodies. As shown in [Fig. 10](#fig10){ref-type="fig"} (A and B), the tyrosine phosphorylation of these molecules was not changed by expressing EGFP-pax~S85A~, suggesting that phosphorylation of paxillin by p38MAPK is not involved in regulating the tyrosine phosphorylation of these proteins.

![**p38MAPK-mediated phosphorylation of paxillin influences the binding of Pyk2 to paxillin.** PC-12 cells expressing EGFP-paxillin β or EGFP-pax~S85A~ were induced with 100 ng/ml NGF for 2 d. Cells were lysed and lysates were directly mixed with SDS sample buffer. Samples were analyzed by SDS-PAGE and transferred to nitrocellulose membrane for probing tyrosine phosphorylation of paxillin, FAK, and Src with phospho-specific antibodies (A). Alternatively, the lysates were immunoprecipitated with anti-GFP antibodies. The immune complexes were solubilized in SDS sample buffer. Samples were analyzed for tyrosine phosphorylation of paxillin and paxillin binding of vinculin, FAK, and Pyk2 (B).](200307081f10){#fig10}

Because paxillin is a focal adhesion adaptor interacting with a number of signaling and adhesion proteins, such as vinculin, FAK, and Pyk2, we tested the interaction of EGFP-paxillin and EGFP-pax~S85A~ with these molecules in NGF-induced cells, respectively. Although EGFP-paxillin and EGFP-pax~S85A~ had the same ability to bind vinculin and FAK, EGFP-paxillin more efficiently associated with Pyk2 than EGFP-pax~S85A~ ([Fig. 10](#fig10){ref-type="fig"} B). Because phosphorylation of paxillin by p38MAPK in vitro had no significant effect on its binding to Pyk2, it is unclear how phosphorylation of paxillin influences the interaction between paxillin and Pyk2. Nevertheless, because Pyk2 is involved in regulating neurite extension and focal adhesions ([@bib10]; [@bib21]; [@bib30]), the interaction of paxillin with Pyk2 may play a role in these processes.

Discussion
==========

p38MAPK plays an important role in neurite extension
----------------------------------------------------

It has been demonstrated that sustained activation of Erk and the consequent stimulation of cdk5 are involved in neurite outgrowth in many systems ([@bib23]; [@bib6]; [@bib2]). However, it has been reported that inhibition of sustained phase of Erk activation does not block neurite outgrowth ([@bib36]). Also, c-Src and bone morphogenetic protein 2 are unable to induce the activation of Erk but still induce neurite outgrowth ([@bib11]; [@bib35]), indicating that multiple signaling pathways are involved in neurite outgrowth.

Several lines of evidence indicate that p38MAPK is essential for neurite outgrowth. First, SB203580, an inhibitor of p38MAPK, blocks neurite outgrowth in several systems ([@bib17]; [@bib11]; [@bib5]; [@bib9]). Second, a dominant negative mutant of p38MAPK also inhibits neurite outgrowth induced by NGF and forskolin ([@bib17]; [@bib5]). Third, activation of p38MAPK by expressing constitutively active MKK3/MKK6, the kinases that phosphorylate and activate p38, induces neurite outgrowth in the absence of growth factor stimulation ([@bib11]).

Paxillin is a substrate for p38MAPK in vitro and in NGF-stimulated cells
------------------------------------------------------------------------

It has been suggested that paxillin is a substrate for Erk in hepatocyte growth factor--stimulated epithelial and PMA-induced thymoma cells ([@bib13]; [@bib16]). However, it is unclear whether paxillin is a direct substrate for Erk in these cells. Here, we show that Erk2 phosphorylates paxillin in vitro at two major sites and that Ser 85 is a minor phosphorylation site for Erk in vitro ([Fig. 3](#fig3){ref-type="fig"}), whereas Ser 85 of exogenously expressed human paxillin (Ser 83 for the endogenous rat paxillin) is major site in NGF-stimulated PC-12 cells ([Fig. 4](#fig4){ref-type="fig"}). Also, treatment of PC-12 cells with PD98058 only partially inhibits NGF-induced phosphorylation of Ser 83 ([Fig. 1](#fig1){ref-type="fig"}). The partial inhibition could be due to the indirect inhibition of p38MAPK because it has reported that constitutive activation of MEK1, the upstream kinase of Erk and the target for PD98059, up-regulates p38MAPK activity in PC-12 cells ([@bib17]). Thus, Erk may be upstream of paxillin, but may not be directly responsible for Ser 83 phosphorylation in NGF-stimulated PC-12 cells.

There is a consensus site (Ser 244) for cdk5 on paxillin. Also, NGF induces paxillin phosphorylation with a similar time course as cdk5 activation ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). This had led us to suspect that paxillin could be a substrate for cdk5 in NGF-stimulated PC-12 cells. However, our experiments indicate that Ser 244, the consensus and the major phosphorylation site for cdk5 in vitro, is not phosphorylated in NGF-stimulated PC-12 cells ([Fig. 4](#fig4){ref-type="fig"}). Also, the phosphorylation of Ser 85 is not significantly inhibited by two cdk5 inhibitors ([Figs. 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Therefore, cdk5 is not involved in the phosphorylation of Ser 85 in PC-12 cells.

p38MAPK has been implicated in heregulin β1--induced paxillin phosphorylation in breast cancer cells ([@bib33]). Paxillin phosphorylation induced by heregulin β1 was partially inhibited by a p38 inhibitor SB203580 and a dominant negative mutant of p38MAPK, but not by PD98059 ([@bib33]). Here, we show that p38MAPK phosphorylates human paxillin at three major sites in vitro ([Fig. 3](#fig3){ref-type="fig"}) and rat paxillin at one major site ([Fig. 6](#fig6){ref-type="fig"}). Ser 85 was unambiguously identified as one of the major p38MAPK phosphorylation sites on human paxillin in vitro and a major NGF-induced phosphorylation site of exogenous paxillin in PC-12 cells ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Also, Ser 83 was identified as the major p38MAPK phosphorylation site on rat paxillin in vitro and a major phosphorylation site of endogenous paxillin in PC-12 cells ([Figs. 1](#fig1){ref-type="fig"} and [6](#fig6){ref-type="fig"}). Because the sequence of rat paxillin around Ser 83 is homologous to that of human paxillin around Ser 85, and the Ser 83 and Ser 85 sites are so close ([Fig. 6](#fig6){ref-type="fig"} C), suggesting that the two sites are likely comparable. Furthermore, the phosphorylation of Ser 85 is completely abolished by a p38MAPK inhibitor SB203580 in NGF-stimulated PC-12 cells ([Fig. 5](#fig5){ref-type="fig"}). Thus, p38MAPK is a kinase that directly phosphorylates paxillin in NGF-stimulated PC-12 cells.

Phosphorylation of paxillin is involved in neurite extension of PC-12 cells
---------------------------------------------------------------------------

The role of cell adhesions in neurite extension has been established previously ([@bib10]; [@bib25]; [@bib34]). As an important component of adhesions, paxillin is also involved in neurite outgrowth ([@bib10]). Although expression of wt paxillin does not influence the neurite outgrowth, expression of a LD4-deleted paxillin mutant significantly inhibits the neurite outgrowth of PC-12 cells ([@bib10]). Expression of v-Crk, an adaptor protein that binds to tyrosine phosphorylated paxillin, promotes neurite formation ([@bib7]). Surprisingly, expression of paxillin mutant (Y31F, Y118F, Y187F), which is deficient in tyrosine phosphorylation and unable to bind Crk, has no effect on neurite extension ([@bib10]). This result indicates that tyrosine phosphorylation of paxillin is not essential for neurite outgrowth in PC-12 cells.

Recently, we demonstrated that phosphorylation of Ser 178 on paxillin by JNK regulates cell migration in several cell types ([@bib8]). However, JNK is not activated and Ser178 is not phosphorylated in NGF-stimulated PC-12 cells (unpublished data). Instead, the activity of p38MAPK is up-regulated and the phosphorylation level of Ser 85 increases. Moreover, expression of a paxillin mutant pax~S85A~ significantly retards NGF-induced neurite extension ([Fig. 7](#fig7){ref-type="fig"}), indicating the involvement of phosphorylation of Ser 85 by p38MAPK in NGF-induced neurite extension. Thus, two types of different cell motility are regulated by two related pathways through phosphorylating their common substrate-paxillin at distinct sites.

Paxillin phosphorylation by p38MAPK is also involved in cell adhesion reorganization
------------------------------------------------------------------------------------

It has been reported that heregulin β1 induces p38MAPK activation and serine phosphorylation on paxillin, resulting in focal adhesion disassembly ([@bib33]). In another report, collagen I stimulates the activities of p38MAPK accompanying a decrease in focal adhesion in endothelial cells, without affecting MAPK kinase, focal adhesion kinase, or phosphatidylinositol 3-kinase ([@bib29]). It is known that focal adhesions undergo reorganization when PC-12 cells are induced to differentiate by NGF ([@bib25]). Here, we show that either a p38MAPK dominant negative mutant or a paxillin mutant (pax~S85A~) cause clustered focal adhesions, whereas MKK3bE, a constitutively active MAPK kinase for p38MAPK, induces focal adhesion disassembly when they are expressed in NGF-treated PC-12 ([Figs. 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}; Fig. S3), suggesting that paxillin phosphorylation by p38MAPK is involved in focal adhesion organization.

How p38MAPK-mediated phosphorylation of paxillin modulates focal adhesions and neurite extension remains to be elucidated. The phosphorylation of paxillin may facilitate the interaction of paxillin with Pyk2, a nonreceptor protein tyrosine kinase that is involved in regulating focal adhesion dynamics and neurite extension ([@bib10]; [@bib21]; [@bib30]). Pyk2 may in turn phosphorylate the Arf-GTPase--activating protein ASAP1 and 3-phosphoinositide--dependent protein kinase 1, or activate Rho pathway ([@bib12]; [@bib20]; [@bib30]). All these signaling events regulate focal adhesion dynamics and may modulate neurite extension. However, other currently unknown mechanisms may also mediate the role of paxillin phosphorylation. For example, we found that a phosphorylated degradation product of paxillin (∼50 kD) was generated after NGF stimulation in PC-12 cells (unpublished data), implying that paxillin phosphorylation may be involved in its degradation. Further studies are required to understand the focal adhesion dynamics during NGF-induced differentiation of PC-12 cells and to fully elucidate the role of serine phosphorylation of paxillin in the regulation of focal adhesion structure.

Materials and methods
=====================

Reagents
--------

Active cdk5/p35 was purchased from Novagen; active p42MAPK was purchased from New England Biolabs, Inc.; Trypsin (sequencing grade) was purchased from Promega; and Flag-p38α, -p38αAF, and -MKK3bE in pcDNA3.1 vector and His-tagged MKK6Eb were gifts from J. Han (Scripps Research Institute, La Jolla, CA). Human paxillin cDNA was a gift from H. Sabe (Osaka Bioscience Institute, Osaka, Japan). Zip-Tips were purchased from Millipore; Ni-NTA-agarose and PQE-30 vector were purchased from QIAGEN; Pfu and Quick-Change mutation kit were purchased from Stratagene; PD98059 and SB203580 were purchased from Calbiochem; roscovitine, purvalanol, rat tail collagen I, antivinculin mAb, and NGF were purchased from Sigma-Aldrich; γ-\[^32^P\]ATP was purchased from NEN Life Science Products; \[^32^P\]orthophosphate was purchased from ICN Biomedicals; Alexa Fluor 568 protein labeling kit was purchased from Molecular Probes; antipaxillin mAbs were purchased from Upstate Biotechnology; anti-GFP pAbs were purchased from CLONTECH Laboratories, Inc.; and rat phaeochromocytoma PC-12 cells were obtained from W. Snider\'s lab and cultured in RPMI 1640 supplemented with 10% horse serum, 5% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin.

Plasmid construction
--------------------

To generate His-tagged p38α, DNA fragments encoding p38α were amplified by pfu-based PCR using Flag-p38α as template and 5′-TTACTTGGATCCCAGGAGAGGCCCACGTTC-3′ and 5′-TTTTTTCTGCAGTCAGGACTCCATTTCTTCTTGGTC-3′ as primers, and subcloned into PQE-30 vector via BamHI and PstI sites. To create His-tagged paxillin β, DNA fragments encoding paxillin β were amplified by pfu-based PCR using 5′-CGACGACCTCGACGCCCTG-3′ and 5′-AAAAAAGTCGACCTAGCAGAAGAGCTTGAGGAAGCA-3′ as primers, and subcloned into pQE-30 vector through Klenow-blunt BamHI site and SalI. His-tagged pax~S85A~ was created by pfu-based PCR using Quick-Change mutation kit and primer pair 5′-CCTCAGTCCTCAGCACCTGTGTACGGC-3′ and 5′-GCCGTACACAGGTGCTGAGGACTGAGG-3′. To construct EGFP-paxillin β and -pax~S85A~, DNA fragments encoding paxillin β and pax~S85A~ were amplified respectively by pfu-based PCR using primer pair 5′-AAAAAAGAATTCAGACGACCTCGACGCCCT-3′ and 5′-AAAAAAGTCGACCTAGCAGAAGAGCTTGAGGAAGCA-3′, and subcloned into pEGFP-C1 vector through EcoRI site and SalI. The DNA fragments encoding EGFP-paxillin β and EGFP-pax~S85A~ were cut out by sequential treatment with SalI, Klenow, and AgeI and inserted into a retroviral MGIN vector ([@bib14]) through AgeI and Klenow-blunt NotI sites.

Protein purification
--------------------

His-tagged proteins were purified by affinity chromatography using Ni-NTA-agarose. In brief, expression was induced with 1 mM IPTG for 3.5 h, bacteria harvested, and sonicated in a lysis buffer (50 mM Tris-HCl, pH 8.1, 300 mM NaCl, 1% Triton X-100, 1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 20 mM imidazole). The cleared lysate was applied to Ni-NTA-agarose column. His-tagged protein was eluted with 250 mM imidazole in 20 mM Tris-HCl, pH 8.1, 300 mM NaCl.

Preparation of viruses and cell infection
-----------------------------------------

Retrovirus packaging cells (293GPG) were maintained in DME supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 1 μg/ml tetracycline, 2 μg/ml puromycin, and 0.3 mg/ml G418. The cells were transfected with MGIN plasmids using Lipofectamine Plus transfection reagent (Invitrogen) according to the manufacturer\'s protocol. To harvest viruses, the transfectants were grown in DME supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. The medium of transfectants was collected at 48 and 72 h, filtered though 0.2-mm filter and applied to overnight cultures of PC-12 cells for infection. Cells stably expressing recombinant proteins were obtained by growing infected PC-12 cells in the presence of 0.7 mg/ml G418 for 1 wk.

In vitro phosphorylation
------------------------

5 μg His-tagged paxillin β was incubated with ∼0.5 μg of kinase in 50 μl of the kinase buffer (20 mM MOPS, pH 7.2, 10 mM MgCl~2~, 25 mM β--glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT) containing 40 μM ATP (10 μCi γ-\[^32^P\]ATP) for 30 min at RT. The reactions were terminated by adding SDS-sample buffer. The samples were subjected to SDS-PAGE and transferred to a nitrocellulose membrane for autoradiography.

In vivo phosphorylation
-----------------------

Cells were incubated with \[^32^P\]orthophosphoric acid in sodium phosphate--deficient MEM (Sigma-Aldrich). After 12 h, cells were harvested and lysed with a RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% IPEGAL, 0.5% deoxycholate, 0.1% SDS, 5 mM EDTA, 1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 500 nM okadaic acid, 1 mM α--naphthyl acid phosphate). The lysates were immunoprecipitated with antipaxillin or anti-GFP antibodies. The immune complexes were analyzed by SDS-PAGE and transferred to nitrocellulose membrane for detection of phosphorylation by autoradiography.

Peptide mapping
---------------

Peptide mapping was performed as described previously ([@bib1]; [@bib8]). In brief, protein bands were cut from nitrocellulose membrane and digested with trypsin (sequencing grade; Promega) in NH~4~HCO~3~, pH 7.8, with shaking at 37°C for 8 h. The samples were dried and washed in a speed-vac, and spotted onto cellulose plate for 2-D phosphopeptide mapping, using pH 8.9 buffer for electrophoresis and phosphochromatography buffer for TLC.

Mass spectrometry
-----------------

Phosphopeptide was recovered from cellulose plates, cleaned up with a Zip-Tip (Millipore) as described previously ([@bib24]) and analyzed by a MALDI-TOF/TOF (Voyager 4700) instrument purchased from Applied Biosystems with α-cyano-4-hydroxy-cinnamic acid as matrix. The instrument was calibrated by external calibration using the ABI 4700 calibration mixture.

Neurite outgrowth
-----------------

PC-12 cells were plated on 35-mm petri dishes precoated with 10 μg/ml collagen I and cultured in RPMI 1640 containing 10% horse serum, 5% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin for overnight, and cultured in DME supplemented with 1% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin for additional 6 h. The cells were then challenged with 100 ng/ml NGF and cultured for 4 d. The neurite outgrowth was photographed using a microscope (model IX81; Olympus) equipped with a 40× objective and a CCD camera (model C4880; Hamamatsu). Scoring for neurite outgrowth of PC-12 cells was performed as described by [@bib3].

EGFP fluorescence, immunofluorescence, and microscopy
-----------------------------------------------------

PC-12 cells expressing EGFP-paxillin β or -pax~S85A~ were plated on MatTek dishes (with a glass coverslip at the bottom) precoated with collagen and treated with 100 ng/ml NGF for 48 h. EGFP epifluorescence and TIRF images were taken at 37°C using a microscope (model IX81; Olympus) equipped with a 60×, 1.45 NA objective, a CCD camera (model C4880; Hamamatsu), and a Metamorph software (Universal Imaging Corp.). For immunofluorescence staining, the cells were fixed with 3% PFA and stained for vinculin with antivinculin mAb prelabeled with Alexa 568. Vinculin staining and EGFP fluorescence were observed and photographed at RT using the same system. The brightness of images were adjusted using Photoshop software.

Protein interaction and tyrosine phosphorylation
------------------------------------------------

PC-12 cells expressing EGFP-paxillin β or EGFP-pax~S85A~ were plated on 100-mm petri dishes precoated with 10 μg/ml collagen I and cultured in normal RPMI 1640 culture medium overnight and cultured in DME supplemented with 1% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin for 12 h. The cells were then induced with 100 ng/ml NGF and cultured for 2 d. Cells were lysed with a buffer containing 50 mM Tris-HCl, pH 7.4, 1% IPEGAL, 100 mM NaCl, 5% glycerol, 5 mM EDTA, 1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 500 nM okadaic acid, 1 mM α--naphthyl acid phosphate, and 1 mM Na~3~VO~4~. The lysates were directly mixed with SDS sample buffer, or were immunoprecipitated with anti-GFP antibodies. Immune complexes were solubilized in SDS sample buffer. Samples were analyzed by SDS-PAGE and transferred to nitrocellulose membrane to detect tyrosine phosphorylation and various protein interactions.

Online supplemental material
----------------------------

Fig. S1 shows that cdk5 directly phosphorylated Ser 244 on paxillin in vitro. To demonstrate that Ser 244 on paxillin is a phosphorylation site for cdk5, wt His-tagged paxillin β or pax~S244A~ were phosphorylated, respectively, with active cdk5/p35 and subjected to 2-D phosphopeptide mapping analysis as described in Peptide mapping section. Fig. S2 demonstrates that NGF-induced neurite extension was inhibited by a p38MAPK inhibitor, SB203580. To test the effect of SB203580 on NGF-induced neurite extension, PC-12 cells were plated on collagen-coated petri dishes, treated with SB203580 as indicated for 10 min, and stimulated with 100 ng/ml NGF without removing the inhibitor. Neurite outgrowth was analyzed after 96 h of NGF stimulation. Fig. S3 suggests that the p38MAPK pathway is involved in regulating focal adhesion reorganization. To explore the role of the p38MAPK pathway in focal adhesion dynamics, PC-12 cells were transiently transfected with EGFP vector, Flag-p38αAF + EGFP vector, and Flag-MKK3bE + EGFP vector for 24 h, and plated on MatTek dishes precoated with 10 μg/ml collagen and treated with 100 ng/ml NGF for 36 h. The cells were fixed and stained with Alexa 568--labeled antivinculin antibodies. Vinculin staining and EGFP fluorescence were viewed by epifluorescence microscopy as described above (EGFP...and microscopy). Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200307081/DC1>.
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